SavedAdd your journal

Journals / Archives of Rheumatology / 2022 / Cilt: 37 - Sayı: 2

case of lupus erythematosus profundus with severe ulceration that responded to tumor necrosis factor-alpha--blocking agents

Daiki NAKAGOMİ
Pages
313–314
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

NAKAGOMİ, D. (2022). case of lupus erythematosus profundus with severe ulceration that responded to tumor necrosis factor-alpha--blocking agents. Archives of Rheumatology, Cilt: 37 - Sayı: 2, 313–314. https://ajindex.com/articles/447952

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Callen JP. Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 2002;16:245-64
  2. Arai S, Katsuoka K. Clinical entity of Lupus erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev 2009;8:449-52
  3. Ueda T, Eto H, Katsuoka K, Takeuchi Y. Lupus erythematosus panniculitis treated with tacrolimus. Eur J Dermatol 2012;22:260-1
  4. Günther C, Aringer M, Lochno M, Kämmerer E, Bauer A, Wozel G, et al. TNF-alpha blockade with infliximab in a patient with lupus erythematosus profundus. Acta Derm Venereol 2012;92:401-3
  5. Aringer M, Graninger WB, Steiner G, Smolen JS. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: An openlabel study. Arthritis Rheum 2004;50:3161-9
  6. Yu C, Chang C, Zhang J. Immunologic and genetic considerations of cutaneous lupus erythematosus: A comprehensive review. J Autoimmun 2013;41:34-45
  7. Goldberg MT, Han YP, Yan C, Shaw MC, Garner WL. TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: An implication for abnormal wound healing. J Invest Dermatol 2007;127:2645-55.